Weekly News Recap #Phispers
FDA chief Gottlieb resigns; BMS-Celgene deal may get derailed due to shareholder opposition
This week, Phispers brings you news about the sudden and unexpected resignation of the USFDA commissioner Scott Gottlieb, a day...
Impressions : 3396
FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation
In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...
Impressions : 5089
Bayer to cut 12,000 jobs; GSK buys cancer drugmaker Tesaro for US$ 5 billion
This week, Phispers has news on German drug major Bayer, which has drawn out a revamp plan that includes plans to slash 12,000 ...
Impressions : 2812
Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan
This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional ...
Impressions : 2759
FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations
This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...
Impressions : 4972
China sees sharp rise in U.S. generic approvals; GSK opts out of Pfizer’s OTC business race
This week,
Phispers brings you news on Pfizer’s OTC auction. After Reckitt Benckiser, even GSK opted out of the race, le...
Impressions : 3737
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.